Operating Income (Loss) of Mosaic ImmunoEngineering Inc. from 31 Aug 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Mosaic ImmunoEngineering Inc. quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Aug 2010 to 30 Sep 2025.
  • Mosaic ImmunoEngineering Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was $144,358, a 23% increase year-over-year.
  • Mosaic ImmunoEngineering Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $618,143, a 38% increase year-over-year.
  • Mosaic ImmunoEngineering Inc. annual Operating Income (Loss) for 2024 was $879,655, a 37% increase from 2023.
  • Mosaic ImmunoEngineering Inc. annual Operating Income (Loss) for 2023 was $1,399,768, a 47% increase from 2022.
  • Mosaic ImmunoEngineering Inc. annual Operating Income (Loss) for 2022 was $2,627,522, a 25% increase from 2021.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Mosaic ImmunoEngineering Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $618,143 $144,358 +$42,072 +23% 01 Jul 2025 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $660,215 $148,854 +$125,448 +46% 01 Apr 2025 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 $785,663 $174,774 +$93,992 +35% 01 Jan 2025 31 Mar 2025 10-Q 20 May 2025 2025 Q1
Q4 2024 $879,655 $150,157 +$125,461 +46% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2024 $1,005,116 $186,430 +$125,441 +40% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2025 2025 Q3
Q2 2024 $1,130,557 $274,302 +$78,204 +22% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2025 2025 Q2
Q1 2024 $1,208,761 $268,766 +$191,007 +42% 01 Jan 2024 31 Mar 2024 10-Q 20 May 2025 2025 Q1
Q4 2023 $1,399,768 $275,618 +$221,936 +45% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $1,621,704 $311,871 +$205,335 +40% 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024 2024 Q3
Q2 2023 $1,827,039 $352,506 +$531,220 +60% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $2,358,259 $459,773 +$269,263 +37% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $2,627,522 $497,554 01 Oct 2022 31 Dec 2022 10-K 15 Apr 2024 2023 FY
Q3 2022 $517,206 +$443,851 +46% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $883,726 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $729,036 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q3 2021 $961,057 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022 2022 Q3
Q4 2011 $781,296 +$960,743 +55% 01 Sep 2011 30 Nov 2011 10-Q 17 Jan 2012 2012 Q2
Q3 2011 $805,221 +$779,281 +49% 01 Jun 2011 31 Aug 2011 10-Q 17 Oct 2011 2012 Q1
Q4 2010 $1,742,039 01 Sep 2010 30 Nov 2010 10-Q 17 Jan 2012 2012 Q2
Q3 2010 $1,584,502 01 Jun 2010 31 Aug 2010 10-Q 17 Oct 2011 2012 Q1

Mosaic ImmunoEngineering Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $879,655 +$520,113 +37% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $1,399,768 +$1,227,754 +47% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $2,627,522 +$873,644 +25% 01 Jan 2022 31 Dec 2022 10-K 15 Apr 2024 2023 FY
2021 $3,501,166 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.